VIALE, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 18.005
EU - Europa 14.231
AS - Asia 6.979
AF - Africa 709
SA - Sud America 106
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 11
Totale 40.099
Nazione #
US - Stati Uniti d'America 17.934
GB - Regno Unito 4.124
IT - Italia 3.598
CN - Cina 2.432
SG - Singapore 2.120
SE - Svezia 1.870
DE - Germania 1.538
VN - Vietnam 1.155
IN - India 797
IE - Irlanda 590
RU - Federazione Russa 496
FR - Francia 427
UA - Ucraina 332
ZA - Sudafrica 236
BG - Bulgaria 225
TG - Togo 214
EE - Estonia 200
CH - Svizzera 186
FI - Finlandia 173
CI - Costa d'Avorio 161
JO - Giordania 141
NL - Olanda 123
ID - Indonesia 105
BE - Belgio 71
NG - Nigeria 71
ES - Italia 64
AU - Australia 55
CA - Canada 50
HK - Hong Kong 46
BR - Brasile 39
AT - Austria 37
IR - Iran 34
RO - Romania 33
HR - Croazia 26
JP - Giappone 26
GR - Grecia 25
CL - Cile 24
PE - Perù 19
PL - Polonia 17
LB - Libano 16
KR - Corea 15
AR - Argentina 13
PK - Pakistan 13
CZ - Repubblica Ceca 12
PT - Portogallo 11
TR - Turchia 11
LT - Lituania 10
SC - Seychelles 10
SK - Slovacchia (Repubblica Slovacca) 10
MX - Messico 9
PH - Filippine 9
TW - Taiwan 9
EU - Europa 8
MY - Malesia 8
SA - Arabia Saudita 7
DK - Danimarca 6
HU - Ungheria 6
MK - Macedonia 6
BD - Bangladesh 5
TH - Thailandia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
IL - Israele 4
NO - Norvegia 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BO - Bolivia 3
EC - Ecuador 3
HN - Honduras 3
LV - Lettonia 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PA - Panama 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BH - Bahrain 2
FK - Isole Falkland (Malvinas) 2
KZ - Kazakistan 2
LY - Libia 2
MN - Mongolia 2
PY - Paraguay 2
AZ - Azerbaigian 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
DO - Repubblica Dominicana 1
EG - Egitto 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MS - Montserrat 1
MU - Mauritius 1
SI - Slovenia 1
SN - Senegal 1
Totale 40.098
Città #
Southend 3.852
Fairfield 2.269
Singapore 1.897
Chandler 1.458
Ashburn 1.431
Santa Clara 1.126
Woodbridge 1.038
Seattle 953
Wilmington 918
Houston 870
Princeton 809
Cambridge 756
Ann Arbor 732
Bologna 679
Dong Ket 612
Dublin 589
Boardman 550
Nanjing 277
Westminster 256
Milan 244
Padova 222
Berlin 221
Lomé 214
Sofia 208
New York 202
Rome 187
San Diego 169
Abidjan 161
Beijing 151
Jinan 150
Saint Petersburg 146
Amman 141
Helsinki 134
Bern 129
Redmond 124
Turin 116
Bremen 114
Shenyang 112
Florence 111
Dearborn 97
Jakarta 95
Des Moines 91
Changsha 88
Nanchang 87
Shanghai 87
Hebei 85
Jacksonville 82
Guangzhou 79
Brescia 76
Redwood City 76
Abeokuta 68
Olalla 66
Brussels 65
Falls Church 63
Jiaxing 63
Tianjin 63
Los Angeles 60
Zhengzhou 55
Mülheim 50
Chicago 46
Norwalk 45
Bühl 44
Hangzhou 44
London 44
Genoa 41
Parma 41
Ningbo 40
Medford 39
Lappeenranta 36
Naples 34
San Francisco 34
Hong Kong 33
Amsterdam 32
Toronto 31
Verona 31
Phoenix 30
Haikou 29
Moscow 29
Paris 29
Kunming 28
Washington 28
Fuzhou 27
Taizhou 27
Frankfurt am Main 26
Mumbai 26
Vicenza 26
Boydton 25
Shenzhen 25
Taiyuan 24
Wuhan 24
Lanzhou 23
Reggio Emilia 23
Tappahannock 23
Chengdu 22
Mountain View 22
Pune 22
San Venanzo 22
São Paulo 22
Catania 21
Pisa 21
Totale 27.063
Nome #
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 518
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 422
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 370
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 343
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. 341
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 238
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients 203
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 199
2017 WSES guidelines on colon and rectal cancer emergencies: Obstruction and perforation 196
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 187
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 182
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 181
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 177
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 174
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 174
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 171
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 170
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 165
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 158
Chagas Disease in a Non-endemic Country: A Multidisciplinary Research, Bologna, Italy 156
A prospective survey of febrile events in hematological malignancies. 154
Bloodstream infections in patients with liver cirrhosis 153
Burkholderia cepacia infection in an infant affected by renal osteodystrophy 152
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 147
Advances in the therapy of bacterial bloodstream infections 145
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 144
Schistosoma mansoni eggs in spleen and lungs, mimicking other diseases 143
null 142
Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study 141
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 141
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 140
Impact of preoperative infection on outcome after liver transplantation 140
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 140
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 140
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 138
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 138
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 138
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 138
PET con FDG nella dialisi peritoneale: le prospettive attuali e future 137
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 136
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz 136
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 135
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 135
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 134
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 134
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 133
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 133
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 133
Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program 133
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 133
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 132
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 132
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 132
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. 131
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 131
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 131
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 131
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 131
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 127
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 127
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 127
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 126
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 123
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 123
A survey on infection management practices in Italian ICUs 122
Plasmodium falciparum malaria in migrants who transited Libya - Where did they contract malaria? 122
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 122
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 122
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts 121
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 121
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection. 121
Pathological post-mortem findings in lungs infected with SARS-CoV-2 121
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy 120
Multiplexed therapeutic drug monitoring (TDM) of antiviral drugs by LC–MS/MS 120
Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia? 119
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 119
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 119
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 119
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 118
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 118
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 118
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 118
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence 117
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 117
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 117
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 117
2013 WSES guidelines for management of intra-abdominal infections 117
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 117
Aggressive versus conservative initiation of antibiotics 117
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 116
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 116
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. 116
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 116
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. 115
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy. 115
Diffuse primary cutaneous infection by Alternaria alternata in a liver transplant recipient with pulmonary nocardiosis: Importance of prompt identification for clinical resolution 115
A risk prediction score for invasive mold disease in patients with hematological malignancies 115
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 115
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 115
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 114
Totale 14.962
Categoria #
all - tutte 123.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.632 0 0 0 0 0 0 1.050 1.125 1.146 540 293 478
2020/20215.559 844 393 225 202 460 357 200 303 506 358 283 1.428
2021/20227.388 582 286 420 581 662 386 245 590 326 753 1.349 1.208
2022/20237.633 763 1.006 394 1.001 570 549 258 515 1.340 275 556 406
2023/20243.631 246 422 234 351 313 575 283 280 185 308 208 226
2024/20257.108 563 1.689 1.136 1.108 1.851 744 17 0 0 0 0 0
Totale 41.482